Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Info on Pfizer Exubera (FUSE) Presentation in Barcelona

Conclusions:

"Based on un-adjudicated reports, there

appears to be a 3.2-fold risk of lung cancer and 2.3-fold

risk of lung cancer mortality among patients randomized

to Exubera. There was no evidence of increased risk of all

cause mortality."

This doesn't sound great for Pfizer,but it's not going to help Afrezza's case either even if it is apples to oranges.

Thanks for sharing,MN.

Share
New Message
Please login to post a reply